| dc.contributor.author | Robaeys, G. | en_US |
| dc.contributor.author | Buntinx, F. | en_US |
| dc.contributor.author | Bottieau, E. | en_US |
| dc.contributor.author | Bourgeois, S. | en_US |
| dc.contributor.author | Brenard, R. | en_US |
| dc.contributor.author | Colle, I. | en_US |
| dc.contributor.author | De Bie, J. | en_US |
| dc.contributor.author | Mathei, C. | en_US |
| dc.contributor.author | Arts, E. J. | |
| dc.contributor.author | Mulkay, J. P. | |
| dc.contributor.author | Van Damme, P. | |
| dc.contributor.author | Van Ranst, M. | |
| dc.contributor.author | Verrando, R. | |
| dc.contributor.author | Michielsen, P. | |
| dc.date.accessioned | 2007-12-06T14:39:04Z | |
| dc.date.available | 2007-12-06T14:39:04Z | |
| dc.date.issued | 2005 | en_US |
| dc.identifier.issn | 0091-5644 | en_US |
| dc.identifier.other | ITG-C3A | en_US |
| dc.identifier.other | CLINIC | en_US |
| dc.identifier.other | U-TROPIC | en_US |
| dc.identifier.other | JIF | en_US |
| dc.identifier.other | CLINIC | |
| dc.identifier.other | U-HIVCLI | |
| dc.identifier.uri | http://hdl.handle.net/10390/965 | |
| dc.language | English | en_US |
| dc.subject | Substance abuse | en_US |
| dc.subject | Viral diseases | en_US |
| dc.subject | Hepatitis C | en_US |
| dc.subject | Chronic diseases | en_US |
| dc.subject | Drug therapy | en_US |
| dc.subject | Interferon | en_US |
| dc.subject | Ribavirin | en_US |
| dc.subject | Transplantation | |
| dc.subject | Surgery | |
| dc.subject | Treatment guidelines | |
| dc.title | Guidelines for the management of chronic hepatitis C in patients infected after substance use | en_US |
| dc.type | Article | en_US |
| dc.citation.issue | 1 | en_US |
| dc.citation.jtitle | Acta Gastro-Enterologica Belgica | en_US |
| dc.citation.volume | 68 | en_US |
| dc.citation.pages | 38-45 | en_US |
| dc.citation.jabbreviation | Acta Gastroenterol Belg | en_US |
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||